1. Home
  2. SLDB vs OZ Comparison

SLDB vs OZ Comparison

Compare SLDB & OZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDB
  • OZ
  • Stock Information
  • Founded
  • SLDB 2013
  • OZ 2020
  • Country
  • SLDB United States
  • OZ United States
  • Employees
  • SLDB N/A
  • OZ N/A
  • Industry
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • OZ
  • Sector
  • SLDB Health Care
  • OZ
  • Exchange
  • SLDB Nasdaq
  • OZ Nasdaq
  • Market Cap
  • SLDB 234.8M
  • OZ 237.6M
  • IPO Year
  • SLDB 2018
  • OZ N/A
  • Fundamental
  • Price
  • SLDB $7.00
  • OZ $66.00
  • Analyst Decision
  • SLDB Strong Buy
  • OZ
  • Analyst Count
  • SLDB 10
  • OZ 0
  • Target Price
  • SLDB $15.10
  • OZ N/A
  • AVG Volume (30 Days)
  • SLDB 1.7M
  • OZ 1.8K
  • Earning Date
  • SLDB 08-12-2025
  • OZ 01-01-0001
  • Dividend Yield
  • SLDB N/A
  • OZ N/A
  • EPS Growth
  • SLDB N/A
  • OZ N/A
  • EPS
  • SLDB N/A
  • OZ N/A
  • Revenue
  • SLDB N/A
  • OZ $4,077,000.00
  • Revenue This Year
  • SLDB N/A
  • OZ N/A
  • Revenue Next Year
  • SLDB N/A
  • OZ N/A
  • P/E Ratio
  • SLDB N/A
  • OZ N/A
  • Revenue Growth
  • SLDB N/A
  • OZ 94.70
  • 52 Week Low
  • SLDB $2.41
  • OZ $56.77
  • 52 Week High
  • SLDB $10.37
  • OZ $82.89
  • Technical
  • Relative Strength Index (RSI)
  • SLDB 75.71
  • OZ 52.15
  • Support Level
  • SLDB $5.74
  • OZ $65.25
  • Resistance Level
  • SLDB $7.12
  • OZ $66.50
  • Average True Range (ATR)
  • SLDB 0.48
  • OZ 0.46
  • MACD
  • SLDB 0.11
  • OZ -0.02
  • Stochastic Oscillator
  • SLDB 94.50
  • OZ 70.45

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About OZ Belpointe PREP LLC Units

Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset.

Share on Social Networks: